- Home
- MRNS vs KUKE Comparison
MRNS vs KUKE Comparison
Compare MRNS & KUKE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MRNS
- KUKE
- Stock Information
- Founded
- MRNS 2003
- KUKE 2002
- Country
- MRNS United States
- KUKE China
- Employees
- MRNS N/A
- KUKE N/A
- Industry
- MRNS Biotechnology: Pharmaceutical Preparations
- KUKE Other Consumer Services
- Sector
- MRNS Health Care
- KUKE Real Estate
- Exchange
- MRNS Nasdaq
- KUKE Nasdaq
- Market Cap
- MRNS 19.0M
- KUKE 21.2M
- IPO Year
- MRNS 2014
- KUKE 2021
- Fundamental
- Price
- MRNS $0.30
- KUKE $0.40
- Analyst Decision
- MRNS Buy
- KUKE
- Analyst Count
- MRNS 12
- KUKE 0
- Target Price
- MRNS $4.28
- KUKE N/A
- AVG Volume (30 Days)
- MRNS 6.6M
- KUKE 1.1M
- Earning Date
- MRNS 11-12-2024
- KUKE 12-26-2024
- Dividend Yield
- MRNS N/A
- KUKE N/A
- EPS Growth
- MRNS N/A
- KUKE N/A
- EPS
- MRNS N/A
- KUKE N/A
- Revenue
- MRNS $31,466,000.00
- KUKE $14,784,158.00
- Revenue This Year
- MRNS $20.74
- KUKE N/A
- Revenue Next Year
- MRNS $32.38
- KUKE N/A
- P/E Ratio
- MRNS N/A
- KUKE N/A
- Revenue Growth
- MRNS 1.63
- KUKE 10.48
- 52 Week Low
- MRNS $0.26
- KUKE $0.33
- 52 Week High
- MRNS $11.26
- KUKE $4.07
- Technical
- Relative Strength Index (RSI)
- MRNS 25.07
- KUKE 37.88
- Support Level
- MRNS $0.29
- KUKE $0.38
- Resistance Level
- MRNS $0.37
- KUKE $0.54
- Average True Range (ATR)
- MRNS 0.04
- KUKE 0.12
- MACD
- MRNS 0.02
- KUKE -0.01
- Stochastic Oscillator
- MRNS 17.95
- KUKE 10.75
About MRNS Marinus Pharmaceuticals Inc.
Marinus Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. It is focused on developing and commercializing innovative therapeutics to treat epilepsy and neuropsychiatric disorders. Marinus manages the business in one segment, which is the identification and development of neuropsychiatric therapeutics. The Company is developing ganaxolone for multiple epilepsy and other neuropsychiatric indications, including adjunctive, or add-on, therapy for the treatment of drug-resistant focal onset seizures; status epilepticus; Fragile X Syndrome, and PCDH19-RE.
About KUKE Kuke Music Holding Limited
Kuke Music Holding Ltd provides classical music licensing, subscription, and education services in China. The company licenses its music content to online music entertainment platforms, such as Tencent Music Entertainment Group, digital music service providers, such as NetEase Cloud Music, as well as film and TV production companies, airlines, and smart hardware companies. Users can access the platform through the website, mobile app, and smart music devices.